In addition, macitentan treatment prevented diabetes-induced VEGF upregulation in these organs (59) and was effective in lowering mean arterial pressure at a median effective dose (ED50) of 1 mg/kg body weight (46). Here, VEGFA is linked to diabetes mellitus.